Calbindin-D28k: role in determining intrinsically generated firing patterns in rat supraoptic neurones.
1. Physiological activation of rat supraoptic nucleus (SON) neurones leads to phasic firing in vasopressin neurones and fast, continuous firing in oxytocin neurones. Using whole-cell patch clamp methods in brain slices, we investigated the role of endogenous calbindin-D28k (calbindin) in determining these intrinsically generated patterns of firing. 2. Direct introduction of calbindin (0.1-0.2 mM) into twelve of twelve phasically firing neurones suppressed Ca(2+)-dependent depolarizing after-potentials (DAPs) and changed activity from phasic to continuous firing. Bovine calcium binding protein (0.3 mM), an analogue of calbindin, had similar effects on both DAPs and firing patterns in five of five cells tested. 3. Introduction of anti-calbindin antiserum (1:2000-5000) into thirteen of thirteen continuously firing neurones unmasked DAPs and converted continuous into phasic firing. Such effects could not be mimicked either by diffusion of normal rabbit serum or antibodies directed against glial fibrillary acidic protein or against neurophysin. 4. Immunocytochemical staining with antisera directed against calbindin revealed more intense staining in the dorsal, oxytocin-rich and less intense staining in the ventral, vasopressin-rich areas of the SON. 5. Elevated intracellular Ca2+ concentration ([Ca2+]i; 0.1 mM) induced DAPs and phasic firing in all twenty-nine SON cells recorded. During chelation of intracellular Ca2+ with (1.1-11 mM) BAPTA, fifty-eight of fifty-eight neurones recorded displayed regular continuous activity and had no DAPs. 6. These data suggest that firing activities in SON cells are dependent on [Ca2+]i and that calbindin, acting as an endogenous Ca2+ buffer, is involved in regulation of intrinsic firing patterns. It is likely that calcium binding proteins have a similar influence on the firing patterns of many neuronal types throughout the nervous system.
Li
Z
Z
Department of Neuroscience, University of California at Riverside 92521, USA.
Decavel
C
C
Hatton
G I
GI
D000200:Action Potentials / Q000502:physiology; D000818:Animals; D000918:Antibody Specificity; D064092:Calbindin 1; D064026:Calbindins; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002417:Cattle; D002614:Chelating Agents; D004533:Egtazic Acid / Q000031:analogs & derivatives; D005260:Female; D007150:Immunohistochemistry; D008297:Male; D009474:Neurons / Q000502:physiology*; D010121:Oxytocin / Q000502:physiology; D018408:Patch-Clamp Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D064030:S100 Calcium Binding Protein G / Q000276:immunology / Q000502:physiology*; D013495:Supraoptic Nucleus / Q000166:cytology*; D014667:Vasopressins / Q000502:physiology
C576500:Calb1 protein, rat; D064092:Calbindin 1; D064026:Calbindins; D002614:Chelating Agents; D064030:S100 Calcium Binding Protein G; D014667:Vasopressins; D010121:Oxytocin; D004533:Egtazic Acid; C025603:1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; D002118:Calcium